Israeli high-tech funding and M&A gain in 2025 despite ongoing Gaza war
By Steven Scheer
JERUSALEM, Sept 30 (Reuters) - Israeli high-tech companies raised $11.9 billion over the first three quarters of 2025 as the technology sector continues to thrive despite Israel's two-year-old war against Hamas militants in Gaza.
Funding was 13% higher than in January to September 2024, the nonprofit Startup Nation Central said on Tuesday. It noted that the volume of funding, which was led by cybersecurity firms, rose despite a 22% decline in the number of deals to 569.
At the same time, mergers and acquisitions reached a record $71 billion so far in 2025, nearly five times higher than the same period in 2024, and largely driven by Alphabet's GOOGL.O $32 billion acquisition of cyber firm Wiz and Palo Alto Networks' PANW.O $25 billion purchase of CyberArk CYBG.F.
The tech sector is a driver of Israel's economy, accounting for about 20% of GDP, 15% of jobs and more than 50% of exports.
In the third quarter, Israeli tech firms raised $2.4 billion, up 9% from the same period in 2024 but down 50% from the second quarter. The number of deals contracted to 141, down 24% from the second quarter and 38% year over year. M&A in the quarter reached nearly $32 billion due to the Palo Alto-CyberArk deal.
"The third quarter of 2025 highlighted a market in transition. While funding slowed and investors became more selective, M&A activity reached historic highs," said Avi Hasson, CEO of Startup Nation Central.
"We are seeing fewer rounds, but at record sizes, signaling confidence in scale-ready companies. At the same time, global buyers are making some of the boldest bets we’ve ever seen on Israeli tech, especially in cybersecurity."
Related Articles
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 T
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
